{"id":852,"date":"2025-11-24T13:00:29","date_gmt":"2025-11-24T13:00:29","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/11\/24\/new-ms-experimental-therapy-misses-main-goals-in-clinical-trial\/"},"modified":"2025-11-24T13:00:29","modified_gmt":"2025-11-24T13:00:29","slug":"new-ms-experimental-therapy-misses-main-goals-in-clinical-trial","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/11\/24\/new-ms-experimental-therapy-misses-main-goals-in-clinical-trial\/","title":{"rendered":"New MS experimental therapy misses main goals in clinical trial"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/11\/24\/new-ms-experimental-therapy-misses-main-goals-clinical-trial\/\" title=\"New MS experimental therapy misses main goals in clinical trial\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"400\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2025\/03\/ClinicaltrialGraph-800x400.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A clinical trial illustration shows a line chart surrounded by hands, a stethoscope, and pills.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"147272\" \/><\/a><\/p>\n<p>A Phase 2 clinical trial testing PIPE-307, an experimental therapy designed to support myelin repair in people with multiple sclerosis (MS), has failed to meet its primary or secondary efficacy goals. The U.S.-based VISTA trial (NCT06083753) enrolled more than 180 adults with relapsing-remitting MS (RRMS). Participants received one of two PIPE-307 doses or a placebo [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/11\/24\/new-ms-experimental-therapy-misses-main-goals-clinical-trial\/\">New MS experimental therapy misses main goals in clinical trial<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/11\/24\/new-ms-experimental-therapy-misses-main-goals-clinical-trial\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Phase 2 clinical trial testing PIPE-307, an experimental therapy designed to support myelin repair in people with multiple sclerosis (MS), has failed to meet its primary or secondary efficacy goals. The U.S.-based VISTA trial (NCT06083753) enrolled more than 180 adults with relapsing-remitting MS (RRMS). Participants received one of two PIPE-307 doses or a placebo&#8230;<\/p>\n","protected":false},"author":0,"featured_media":853,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-852","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=852"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/852\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/853"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=852"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=852"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}